Valproic acid: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

20 March 2024

  • curprev 05:0305:03, 20 March 2024‎ Lazy talk contribs‎ 1,162 bytes −5‎ No edit summary
  • curprev 05:0105:01, 20 March 2024‎ Lazy talk contribs‎ 1,167 bytes +1,167‎ Created page with "{{TreatmentInfo |drug_name=Valproic Acid/Sodium Valproate (Depakote) |FDA_approval=Yes (for epilepsy) |used_for=Investigational use in glioblastoma for its HDAC inhibition properties |clinical_trial_phase=Retrospective studies and a prospective phase II trial |common_side_effects=Liver enzyme non-induction, potential increase in chemotherapy concentration, somnolence, constipation, potential liver toxicity |OS_without=Median survival with enzyme-inducing anticonvulsants:..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Valproic_acid"